Bacteria

India Water Treatment Chemicals Industry Report 2024: Stringent Environmental Regulations and Increased Awareness Boosts Sector Growth - ResearchAndMarkets.com

Retrieved on: 
Friday, March 15, 2024
Utilities, Other Natural Resources, Sustainability, Energy, Technology, Food, Beverage, Natural Resources, Environment, Retail, Chemicals, Plastics, Food Tech, Manufacturing, GxP, Toxicity, Health, INR, Growth, Urbanization, Acceleration, Bacteria, Water purification, Water quality, Water, Safety, Power, Population growth, Disinfectant, Sewage treatment

The water treatment chemicals sector involves manufacturing and supplying a wide range of chemical products for treating and purifying water in diverse applications.

Key Points: 
  • The water treatment chemicals sector involves manufacturing and supplying a wide range of chemical products for treating and purifying water in diverse applications.
  • These chemicals are utilized in municipal water treatment, industrial processes, wastewater treatment, and other sectors to improve water quality, ensure its safety for consumption, and mitigate environmental impacts.
  • Stringent environmental regulations and increased industry awareness are anticipated to drive significant growth in the wastewater treatment chemicals market.
  • Increasing power plants, coupled with a focus on operational efficiency, drive the demand for water treatment chemicals to optimize cooling and boiler feedwater treatment.

Global Guidewires (Nitinol, Stainless Steel, Others) Market Report 2024: Analysis & Forecasts 2019-2022 and 2023-2029 - Minimally Invasive Techniques Expand, Boosting Guidewire Utilization - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 12, 2024
General Health, Health, Medical Supplies, Medical Devices, Disease, PVI, Friction, ERCP, Coronary artery disease, Conditional sentence, Bacteria, Epidemiology, Specialization, Risk, Investment, Infection, Patient safety, USD, Surgery, Non-communicable disease, Cardiovascular disease, Fungal infection, Obesity, Biotechnology, Peripheral artery disease, Porter's five forces analysis, Diabetes, Chlorhexidine, World Health Organization, Safety, Fatigue, Hypertension, Cardiology, Neurology, Urology, Prevalence, Death, PCI, Diagnosis, Arrhythmia, Temperature, Growth, Incidence, Anatomy, SWOT, Mortality, Stainless steel, WHO, Nickel titanium, Physician, Medical imaging

Guidewires Market is being propelled increasing prevalence of cardiovascular diseases, technological advancements in guidewire design and materials, rising demand for minimally invasive procedures, and expanding healthcare infrastructure in developing economies.

Key Points: 
  • Guidewires Market is being propelled increasing prevalence of cardiovascular diseases, technological advancements in guidewire design and materials, rising demand for minimally invasive procedures, and expanding healthcare infrastructure in developing economies.
  • As the prevalence of risk factors such as obesity, diabetes, and hypertension increase, so does the incidence of cardiovascular diseases.
  • Guidewires are essential tools in percutaneous coronary interventions (PCI), peripheral vascular interventions (PVI), and electrophysiology procedures, driving the demand for guidewires.
  • The increasing prevalence of chronic diseases worldwide drives the demand for guidewires by necessitating minimally invasive interventions for diagnosis and treatment.

Auto-Drain™ Shower System Enhanced with Diverter and Low-Flow Options; Anti-Stagnation Solution for Waterborne HAI Prevention

Retrieved on: 
Thursday, April 4, 2024
Health, Pressure, Caregiver, Risk, Patient, GPM, School, Hospital, Low, Baseflow, Bacteria, Long-term care, Stainless steel, Marketing, EPA, Infection, Water, Hygiene, Plumbing

DES PLAINES, Ill., April 4, 2024 /PRNewswire-PRWeb/ -- Chicago Faucets is pleased to announce the expansion of its Auto-Drain™ Shower System lineup that addresses the critical need for waterborne healthcare acquired infections. The latest enhancements for the first anti-stagnation shower system include a diverter for dual shower sprays. IN addition the Auto-Drain pressure balancing valve 1911 model has been added for facilities that desire a Low Flow shower at 1.50 GPM with integrated stagnation prevention.

Key Points: 
  • The latest enhancements for the first anti-stagnation shower system include a diverter for dual shower sprays.
  • The enhanced Auto-Drain™ Shower System with diverter and low flow options reflects Chicago Faucets commitment to providing healthcare solutions that prioritize both infection control and water conservation.
  • The system comprises the Auto-Drain Valve Diverter, Thermostatic/Pressure Balancing Shower Valve or Pressure Balancing Shower Valve, and the Auto-Drain™ Hose and Hand Spray.
  • To learn more about the enhanced Auto-Drain™ Shower System and its innovative features visit: chicagofaucets.com/autodrain .

Datasea Enters into a Sales Agreement for its Acoustic Products Bringing its Evolutionary Technology to Market in a Strategic Milestone to Develop Rapid Online Sales

Retrieved on: 
Thursday, April 4, 2024
Kirby: Planet Robobot, PDD, Growth, Agreement, RMB, Partnership, COVID-19, Taobao, Sterilization, Sale, Bacteria, Virus, Marketing, Shenzhen, Digital technology, Intelligence, Online shopping

The signing of this Agreement signifies a new milestone for Datasea in promoting the domestic and international sales of its acoustic high tech products and it is expected to be a key driver of the Company's future revenue growth.

Key Points: 
  • The signing of this Agreement signifies a new milestone for Datasea in promoting the domestic and international sales of its acoustic high tech products and it is expected to be a key driver of the Company's future revenue growth.
  • Zhixin Liu, CEO of Datasea, commented, "We are delighted to have signed this Agreement with Xiaoranfang Marketing.
  • This marks a significant milestone in advancing the market promotion and sales of our leading-edge acoustic high tech products.
  • We are confident that our experience with digital sales promotion and online sales channels, with our large customer base, will promote sales of Datasea's products and achieve a win-win situation."

Affinity Biosensors Receives FDA Clearance for the LifeScale AST System

Retrieved on: 
Wednesday, April 3, 2024
Patient, Health, FDA, Sepsis, Bacteria, Fungal infection, Infection, Pharmaceutical industry

SANTA BARBARA, Calif., April 3, 2024 /PRNewswire/ -- Affinity Biosensors, a leading innovator in the field of healthcare diagnostics, announces that its groundbreaking LifeScale AST system has received FDA clearance.

Key Points: 
  • SANTA BARBARA, Calif., April 3, 2024 /PRNewswire/ -- Affinity Biosensors, a leading innovator in the field of healthcare diagnostics, announces that its groundbreaking LifeScale AST system has received FDA clearance.
  • Key features of the LifeScale AST system include:
    Rapid results: LifeScale AST delivers results in under 5 hours, significantly reducing the time needed to select the most appropriate antibiotic therapy for patients.
  • Dr. Ken Babcock, CEO of Affinity Biosensors, said "We are very proud of achieving FDA clearance for the LifeScale AST system.
  • To learn more about Affinity Biosensors and the LifeScale AST system, please visit https://affinitybio.com .

Infinant Health Announces Submission of Orphan Drug Designation Application

Retrieved on: 
Tuesday, April 2, 2024
ODD, Bifidobacterium longum, Health, Disease, Incidence, Partnership, Risk, Necrotizing enterocolitis, Health maintenance organization, Biomarker, Disorder, Milk, Mortality, Bacteria, Infant, Death, United, NEC, Mucus, Marketing, FDA, Food, Pharmaceutical industry

DAVIS, Calif., April 2, 2024 /PRNewswire/ -- Infinant Health, a privately-held company focused on changing the trajectory of human health, one baby at a time, announced it has filed an application with the U.S. Food and Drug Administration (FDA) to receive Orphan Drug Designation (ODD) for its drug candidate INF108 for the prevention of necrotizing enterocolitis in pre-term infants.

Key Points: 
  • DAVIS, Calif., April 2, 2024 /PRNewswire/ -- Infinant Health, a privately-held company focused on changing the trajectory of human health, one baby at a time, announced it has filed an application with the U.S. Food and Drug Administration (FDA) to receive Orphan Drug Designation (ODD) for its drug candidate INF108 for the prevention of necrotizing enterocolitis in pre-term infants.
  • The FDA grants Orphan Drug Designation status to products that treat rare diseases, providing incentives to sponsors developing drugs or biologics.
  • Orphan Drug Designation would qualify INF108 for certain benefits and incentives, including seven years of marketing exclusivity if regulatory approval is ultimately received for the designated indication, potential tax credits for certain activities, eligibility for orphan drug grants, and the waiver of certain administrative fees.
  • The receipt of Orphan Drug Designation status does not change the regulatory requirements or process for obtaining marketing approval.

93-Year-Old Dr. Stanley Taub Redefines Innovation with the iRoller: A Timeless Solution for Touchscreen Ubiquity

Retrieved on: 
Monday, April 1, 2024
Bacteria, System

NEW YORK, April 1, 2024 /PRNewswire/ -- Dr. Stanley Taub, an icon of innovation even at the age of 93, proudly unveils the latest evolution of his pioneering creation: the iRoller.

Key Points: 
  • NEW YORK, April 1, 2024 /PRNewswire/ -- Dr. Stanley Taub, an icon of innovation even at the age of 93, proudly unveils the latest evolution of his pioneering creation: the iRoller.
  • Introduced several years ago, the iRoller has consistently stayed ahead of its time, thanks to Dr. Taub's visionary anticipation of the widespread use of touchscreens in modern society.
  • Dr. Taub's unwavering dedication to quality and innovation is evident in every aspect of the iRoller's design.
  • In an era flooded with cheap imitations and disposable imported gadgets, Dr. Taub's commitment to excellence sets the iRoller apart as a timeless creation.

Keosaa Launches Debut Electric Toothbrush on Amazon for Enhanced Oral Care

Retrieved on: 
Thursday, March 28, 2024
Dental care, Dentistry, Travel, Bacteria, System, Oral hygiene

At Keosaa, we believe that professional dental care should not be confined to the dentist's chair.

Key Points: 
  • At Keosaa, we believe that professional dental care should not be confined to the dentist's chair.
  • This state-of-the-art electric toothbrush is designed with your oral health in mind, featuring advanced brushing technology that ensures a deeper clean, reaching areas manual toothbrushes simply can't.
  • As we observe Oral Health Month, there's no better time to reflect on the importance of maintaining good oral hygiene practices.
  • Endorse the future of Keosaa oral care today and discover how Keosaa's latest electric toothbrush can transform your daily routine.

Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAE

Retrieved on: 
Wednesday, March 27, 2024
Community, Patient, Colostomy, Health care, Bacteria, Quality of life, Shoe, Curriculum, Western world, Abdominal pain, IBD, Immune system, Diarrhea, Disease, Health professional, Crohn's disease, Student, Environment, Caregiver, Incidence, Empathy, Abdomen, Inflammatory bowel disease, HY

DUBAI, UAE, March 27, 2024 /PRNewswire/ -- Takeda, the patient-centric biopharmaceutical company, brought its global 'In Their Shoes' program to the UAE. The initiative, focused on raising awareness of the difficult symptoms of Inflammatory Bowel Disease (IBD), entailed an immersive 24-hour simulation that generated a deeper understanding of how the disease affects the daily lives of patients.

Key Points: 
  • DUBAI, UAE, March 27, 2024 /PRNewswire/ -- Takeda, the patient-centric biopharmaceutical company, brought its global 'In Their Shoes' program to the UAE.
  • While inflammation is the body's natural reaction to irritation or injury, in patients with IBD, it is thought that the body's own immune system mistakenly identifies a harmless food or bacteria within the gut as 'foreign' and attacks it3.
  • Using a mobile app and an 'IBD kit,' participants engaged in common struggles, gaining insights into the disease's physical and emotional challenges.
  • Although the simulation couldn't fully replicate the experience, it is meant to foster empathy for individuals living with IBD.

Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAE

Retrieved on: 
Wednesday, March 27, 2024
Community, Patient, Colostomy, Health care, Bacteria, Quality of life, Shoe, Curriculum, Western world, Abdominal pain, IBD, Immune system, Diarrhea, Disease, Health professional, Crohn's disease, Student, Environment, Caregiver, Incidence, Empathy, Abdomen, Inflammatory bowel disease, HY

DUBAI, UAE, March 27, 2024 /PRNewswire/ -- Takeda, the patient-centric biopharmaceutical company, brought its global 'In Their Shoes' program to the UAE. The initiative, focused on raising awareness of the difficult symptoms of Inflammatory Bowel Disease (IBD), entailed an immersive 24-hour simulation that generated a deeper understanding of how the disease affects the daily lives of patients.

Key Points: 
  • DUBAI, UAE, March 27, 2024 /PRNewswire/ -- Takeda, the patient-centric biopharmaceutical company, brought its global 'In Their Shoes' program to the UAE.
  • While inflammation is the body's natural reaction to irritation or injury, in patients with IBD, it is thought that the body's own immune system mistakenly identifies a harmless food or bacteria within the gut as 'foreign' and attacks it3.
  • Using a mobile app and an 'IBD kit,' participants engaged in common struggles, gaining insights into the disease's physical and emotional challenges.
  • Although the simulation couldn't fully replicate the experience, it is meant to foster empathy for individuals living with IBD.